BAGALONI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 1.694
EU - Europa 903
AS - Asia 660
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 18
OC - Oceania 17
Totale 3.437
Nazione #
US - Stati Uniti d'America 1.652
CN - Cina 262
SG - Singapore 219
IT - Italia 213
GB - Regno Unito 141
RU - Federazione Russa 132
UA - Ucraina 106
SE - Svezia 90
BR - Brasile 60
FR - Francia 59
TR - Turchia 56
DE - Germania 55
VN - Vietnam 47
FI - Finlandia 32
IE - Irlanda 27
CA - Canada 18
AU - Australia 16
MX - Messico 15
HK - Hong Kong 13
IN - India 13
ES - Italia 11
AR - Argentina 8
JP - Giappone 8
PL - Polonia 8
ZA - Sudafrica 8
NL - Olanda 7
IQ - Iraq 6
KR - Corea 6
BD - Bangladesh 5
BE - Belgio 4
EG - Egitto 4
IR - Iran 4
LT - Lituania 4
AT - Austria 3
EC - Ecuador 3
ID - Indonesia 3
LK - Sri Lanka 3
MA - Marocco 3
BH - Bahrain 2
EU - Europa 2
GD - Grenada 2
MD - Moldavia 2
PK - Pakistan 2
PR - Porto Rico 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.374
Città #
Ashburn 231
Fairfield 173
Woodbridge 141
Singapore 135
Southend 109
Houston 94
Cambridge 83
Ann Arbor 82
Seattle 77
Jacksonville 75
San Jose 65
Wilmington 63
Beijing 52
Chandler 46
New York 44
Dallas 37
Nanjing 35
Boardman 30
Urbino 30
Izmir 29
Los Angeles 25
Dublin 22
Ho Chi Minh City 18
Council Bluffs 17
Lauterbourg 17
Helsinki 16
Bremen 15
Düsseldorf 15
Princeton 15
Hebei 14
Hong Kong 13
Santa Clara 13
Sydney 13
Dearborn 12
Moscow 12
Milan 11
San Francisco 11
Tianjin 11
Chicago 10
Shenyang 10
Brooklyn 9
Rome 9
San Diego 9
São Paulo 9
Changsha 8
Frankfurt am Main 8
Guangzhou 8
Hanoi 8
Istanbul 8
London 8
Redwood City 8
Vittuone 8
Boston 7
Jiaxing 7
Jinan 7
Johannesburg 7
Kocaeli 7
Pontedera 7
Tokyo 7
Atlanta 6
Bisceglie 6
Denver 6
Nanchang 6
Nuremberg 6
Toronto 6
Cagliari 5
Montreal 5
Poplar 5
Rimini 5
The Dalles 5
Ankara 4
Brussels 4
Kunming 4
Lappeenranta 4
Leawood 4
Menlo Park 4
Mexico City 4
Portland 4
Querétaro 4
Redondo Beach 4
San Mateo 4
Seongnam 4
Turku 4
Warsaw 4
Augusta 3
Buffalo 3
Cairo 3
Canberra 3
Colombo 3
Des Moines 3
Elk Grove Village 3
Gurgaon 3
Lecce 3
Ningbo 3
Quito 3
Shanghai 3
Strasbourg 3
Sulaymaniyah 3
Acton 2
Ardabil 2
Totale 2.233
Nome #
XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT 315
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 296
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. 268
DNA demethylating antineoplastic strategies: a comparative point of view. 261
Malten, a new synthetic molecule showing in vitro antiproliferative activity against tumor cells and induction of complex DNA structural alterations. 226
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with Ramucirumab-Paclitaxel or standard chemotherapy 217
Sex-Related Differences in Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy 216
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomized, phase III adjuvant TOSCA trial in high-risk colon cancer patients. 194
Patients treated with FOLFOX-4 or XELOX chemotherapy with high-risk stage II and III colon cancer (TOSCA trial): a different impact of pharmacogenetic profile on toxicity in women and men 172
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib 170
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with antiangiogenic or standard chemotherapy regimens 155
A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy 150
Glycolytic competence in gastric adenocarcinomas negatively impacts on survival outcomes of patients treated with salvage paclitaxel-ramucirumab. 145
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES MAY AFFECT THE LOSS OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 143
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma 139
Warburg effect and tp53 mutational status in gastric cancer patients under ramucirumab-based therapy 135
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES AFFECT THE DURATION OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 126
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy 109
Totale 3.437
Categoria #
all - tutte 13.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022248 0 15 13 63 9 14 9 32 15 10 22 46
2022/2023218 43 11 11 16 23 39 4 10 39 4 9 9
2023/2024147 13 10 4 11 12 44 4 8 0 20 4 17
2024/2025402 18 10 74 23 18 25 93 15 15 45 54 12
2025/2026913 120 70 89 192 84 83 72 31 64 65 35 8
2026/202731 23 8 0 0 0 0 0 0 0 0 0 0
Totale 3.437